Tatva Chintan Pharma Chem

Tatva Chintan soars 17% on robust Q2 nos; stock up 130% from issue price

In Q2FY22, the company's consolidated net profit jumped an over nine-fold to Rs 32.41 crore against Rs 3.56 crore in Q2FY21

Stocks to Watch: RIL, HDFC AMC, ICRA, SRF, Tech Mahindra, Ceat, ICICI Bank

The markets are likely to react to Reliance and ICICI Bank results at the opening bell today

Sensex gyrates 376 pts, ends 66 pts down; Sun Pharma zooms 10%, Tech M 7%

Domestic equities witnessed sharp profit booking in the fag end of the session as European stocks slipped in early trade and US stock futures hinted at a muted start on Wall Street later today

Stocks to watch: TechM, Concor, Bandhan Bank, UPL, Tatva Chintan, TVS Motor

State-owned Container Corporation of India (Concor) reported a 409.67 per cent YoY surge in consolidated net profit to Rs 251.22 crore for the first quarter ended June 30

Tatva Chintan zooms 113% to Rs 2,310 in highest listing gain this year

Issue price was Rs 903 per share, IPO had garnered 180x subscription